☰

Satish K. Pillai, Ph.D. - Publications

Affiliations: 
2005 University of California, San Diego, La Jolla, CA 
Area:
Genetics, Molecular Biology
Tree Info Similar researchers PubMed Report error

63 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Bouzidi MS, Dossani ZY, Benedetto CD, Raymond KA, Desai S, Chavez LR, Betancur P, Pillai SK. High-resolution Inference of Multiplexed Anti-HIV Gene Editing using Single-Cell Targeted DNA Sequencing. Biorxiv : the Preprint Server For Biology. PMID 38328062 DOI: 10.1101/2024.01.24.576921  0.362
2023 Sperber HS, Raymond KA, Bouzidi MS, Ma T, Valdebenito S, Eugenin EA, Roan NR, Deeks SG, Winning S, Fandrey J, Schwarzer R, Pillai SK. The hypoxia-regulated ectonucleotidase CD73 is a host determinant of HIV latency. Cell Reports. 42: 113285. PMID 37910505 DOI: 10.1016/j.celrep.2023.113285  0.337
2023 Premeaux TA, Yeung ST, Pillai SK, Ndhlovu LC. Elevated Galectin-9 across the human brain correlates with HIV neuropathology and detrimental cognitive states. Journal of Neurovirology. PMID 37233903 DOI: 10.1007/s13365-023-01149-9  0.343
2021 Egedal JH, Xie G, Packard TA, Laustsen A, Neidleman J, Georgiou K, Pillai SK, Greene WC, Jakobsen MR, Roan NR. Hyaluronic acid is a negative regulator of mucosal fibroblast-mediated enhancement of HIV infection. Mucosal Immunology. PMID 33976386 DOI: 10.1038/s41385-021-00409-3  0.368
2021 Gramatica A, Schwarzer R, Brantley W, Varco-Merth B, Sperber HS, Hull PA, Montano M, Migueles SA, Rosenthal D, Hogan LE, Johnson JR, Packard TA, Grimmett ZW, Herzig E, Besnard E, ... ... Pillai SK, et al. Evaluating a New Class of AKT/mTOR Activators for HIV Latency Reversing Activity . Journal of Virology. PMID 33536176 DOI: 10.1128/JVI.02393-20  0.308
2020 Rutishauser RL, Deguit CDT, Hiatt J, Blaeschke F, Roth TL, Wang L, Raymond KA, Starke CE, Mudd JC, Chen W, Smullin CP, Matus-Nicodemos R, Hoh R, Krone MR, Hecht FM, ... ... Pillai SK, et al. TCF-1 regulates HIV-specific CD8+ T cell expansion capacity. Jci Insight. PMID 33351785 DOI: 10.1172/jci.insight.136648  0.331
2020 Sperber HS, Togarrati PP, Raymond KA, Bouzidi MS, Gilfanova R, Gutierrez AG, Muench MO, Pillai SK. μ-Lat: A mouse model to evaluate human immunodeficiency virus eradication strategies. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. PMID 32901981 DOI: 10.1096/Fj.202001612Rr  0.465
2020 Vallejo-Gracia A, Chen IP, Perrone R, Besnard E, Boehm D, Battivelli E, Tezil T, Krey K, Raymond KA, Hull PA, Walter M, Habrylo I, Cruz A, Deeks S, Pillai S, et al. FOXO1 promotes HIV latency by suppressing ER stress in T cells. Nature Microbiology. PMID 32541947 DOI: 10.1038/S41564-020-0742-9  0.449
2020 Marques de Menezes EG, Jang K, George AF, Nyegaard M, Neidleman J, Inglis HC, Danesh A, Deng X, Afshari A, Kim YH, Billaud JN, Marson K, Pilcher CD, Pillai SK, Norris PJ, et al. Seminal plasma-derived extracellular vesicle fractions from HIV-infected men exhibit unique miRNA signatures and induce a pro-inflammatory response in cells isolated from the female reproductive tract. Journal of Virology. PMID 32434889 DOI: 10.1128/Jvi.00525-20  0.472
2019 Li Z, Wu J, Chavez L, Hoh R, Deeks SG, Pillai SK, Zhou Q. Reiterative Enrichment and Authentication of CRISPRi Targets (REACT) identifies the proteasome as a key contributor to HIV-1 latency. Plos Pathogens. 15: e1007498. PMID 30645648 DOI: 10.1371/Journal.Ppat.1007498  0.488
2019 Sperber H, Togarrati PP, Raymond K, Bouzidi MS, Gilfanova R, Muench MO, Pillai SK. μ-Lat: a high-throughput humanised mouse model of latent HIV infection Journal of Virus Eradication. 5: 19. DOI: 10.1016/S2055-6640(20)30119-9  0.442
2019 Sperber H, Ma T, Roan NR, Pillai SK. Expression profiling of HIV latently-infected cells using nanostring and mass cytometry Journal of Virus Eradication. 5: 1. DOI: 10.1016/S2055-6640(20)30070-4  0.433
2018 Premeaux TA, D'Antoni ML, Abdel-Mohsen M, Pillai SK, Kallianpur KJ, Nakamoto BK, Agsalda-Garcia M, Shiramizu B, Shikuma CM, Gisslén M, Price RW, Valcour V, Ndhlovu LC. Elevated cerebrospinal fluid Galectin-9 is associated with central nervous system immune activation and poor cognitive performance in older HIV-infected individuals. Journal of Neurovirology. PMID 30478799 DOI: 10.1007/S13365-018-0696-3  0.458
2018 Battivelli E, Dahabieh MS, Abdel-Mohsen M, Svensson JP, Tojal Da Silva I, Cohn LB, Gramatica A, Deeks S, Greene WC, Pillai SK, Verdin E. Distinct chromatin functional states correlate with HIV latency reactivation in infected primary CD4 T Cells. Elife. 7. PMID 29714165 DOI: 10.7554/Elife.34655  0.469
2018 Battivelli E, Dahabieh MS, Abdel-Mohsen M, Svensson JP, Silva ITD, Cohn LB, Gramatica A, Deeks S, Greene WC, Pillai SK, Verdin E. Author response: Distinct chromatin functional states correlate with HIV latency reactivation in infected primary CD4+ T cells Elife. DOI: 10.7554/Elife.34655.028  0.415
2018 Battivelli E, Dahabieh MS, Abdel-Mohsen M, Svensson JP, Da Silva IT, Cohn LB, Gramatica A, Deeks S, Greene W, Pillai SK, Verdin E. D-106 Chromatin Functional States Correlate with the Reversal of Latently HIV-1 Infected Primary CD4+ T cells Jaids Journal of Acquired Immune Deficiency Syndromes. 77: 40. DOI: 10.1097/01.Qai.0000532598.61340.64  0.407
2017 Bangirana P, Ruel TD, Boivin MJ, Pillai SK, Giron LB, Sikorskii A, Banik A, Achan J. Absence of neurocognitive disadvantage associated with paediatric HIV subtype A infection in children on antiretroviral therapy. Journal of the International Aids Society. 20. PMID 29052340 DOI: 10.1002/Jia2.25015  0.421
2017 Krarup AR, Abdel-Mohsen M, Schleimann MH, Vibholm L, Engen PA, Dige A, Wittig B, Schmidt M, Green SJ, Naqib A, Keshavarzian A, Deng X, Olesen R, Petersen AM, Benfield T, ... ... Pillai SK, et al. The TLR9 agonist MGN1703 triggers a potent type I interferon response in the sigmoid colon. Mucosal Immunology. PMID 28766555 DOI: 10.1038/Mi.2017.59  0.391
2017 Henrich TJ, Deeks SG, Pillai SK. Measuring the Size of the Latent Human Immunodeficiency Virus Reservoir: The Present and Future of Evaluating Eradication Strategies. The Journal of Infectious Diseases. 215: S134-S141. PMID 28520968 DOI: 10.1093/Infdis/Jiw648  0.44
2017 Pillai SK, Deeks SG. Signature of the Sleeper Cell: A Biomarker of HIV Latency Revealed. Trends in Immunology. PMID 28511815 DOI: 10.1016/J.It.2017.04.007  0.452
2017 Keating SM, Pilcher CD, Jain V, Lebedeva M, Hampton D, Abdel-Mohsen M, Deng X, Murphy G, Welte A, Facente SN, Hecht F, Deeks SG, Pillai SK, Busch MP. HIV Antibodies Detect HIV Persistence and Low Level Viral Replication. The Journal of Infectious Diseases. PMID 28498985 DOI: 10.1093/Infdis/Jix225  0.464
2017 Vibholm L, Schleimann MH, Højen JF, Benfield T, Offersen R, Rasmussen K, Olesen R, Dige A, Agnholt J, Grau J, Buzon M, Wittig B, Lichterfeld M, Petersen AM, Deng X, ... ... Pillai SK, et al. Short-course TLR9 Agonist Treatment Impacts Innate Immunity and Plasma Viremia in Individuals with HIV infection. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 28329286 DOI: 10.1093/Cid/Cix201  0.402
2017 Oussayef NL, Pillai SK, Honein MA, Ben Beard C, Bell B, Boyle CA, Eisen LM, Kohl K, Kuehnert MJ, Lathrop E, Martin SW, Martin R, McAllister JC, McClune EP, Mead P, et al. Zika Virus -10 Public Health Achievements in 2016 and Future Priorities. Mmwr. Morbidity and Mortality Weekly Report. 65: 1482-1488. PMID 28056005 DOI: 10.15585/Mmwr.Mm6552E1  0.302
2017 Jacobs ES, Keating SM, Abdel-Mohsen M, Gibb SL, Heitman JW, Inglis HC, Martin JN, Zhang J, Kaidarova Z, Deng X, Wu S, Anastos K, Crystal H, Villacres MC, Young M, ... ... Pillai SK, et al. Cytokines Elevated in HIV Elite Controllers Reduce HIV Replication in vitro and Modulate HIV Restriction Factor Expression. Journal of Virology. PMID 28053103 DOI: 10.1128/Jvi.02051-16  0.479
2017 Munoz-Arias I, Hanhauser E, Hogan L, Mohsen MA, Hobbs K, Thanh C, Gibson E, Deeks SG, Pillai SK, Henrich TJ. OA2-3 Small-molecule chemotherapeutic drugs reactivate HIV-1 via non-canonical pathways and modulate CD8 T cell response Journal of Virus Eradication. 3: 2-3. DOI: 10.1016/S2055-6640(20)30837-2  0.378
2016 Abdel-Mohsen M, Chavez L, Tandon R, Chew GM, Deng X, Danesh A, Keating S, Lanteri M, Samuels ML, Hoh R, Sacha JB, Norris PJ, Niki T, Shikuma CM, Hirashima M, ... ... Pillai SK, et al. Human Galectin-9 Is a Potent Mediator of HIV Transcription and Reactivation. Plos Pathogens. 12: e1005677. PMID 27253379 DOI: 10.1371/Journal.Ppat.1005677  0.496
2015 Abdel-Mohsen M, Wang C, Strain MC, Lada SM, Deng X, Cockerham LR, Pilcher CD, Hecht FM, Liegler T, Richman DD, Deeks SG, Pillai SK. Select host restriction factors are associated with HIV persistence during antiretroviral therapy. Aids (London, England). 29: 411-20. PMID 25602681 DOI: 10.1097/Qad.0000000000000572  0.592
2015 Giron LB, Tenore S, Sucupira MCA, Janini LM, Pillai S, Diaz RS. Evidence of ongoing HIV replication during suppressive antiretroviral therapy Journal of Virus Eradication. 1: 29-30. DOI: 10.1016/S2055-6640(20)31370-4  0.436
2014 Abdel-Mohsen M, Deng X, Danesh A, Liegler T, Jacobs ES, Rauch A, Ledergerber B, Norris PJ, Günthard HF, Wong JK, Pillai SK. Role of microRNA modulation in the interferon-α/ribavirin suppression of HIV-1 in vivo. Plos One. 9: e109220. PMID 25275557 DOI: 10.1371/Journal.Pone.0109220  0.409
2014 Raposo RA, Abdel-Mohsen M, Deng X, Hecht FM, Pilcher CD, Pillai SK, Nixon DF. Dynamic regulation of host restriction factor expression over the course of HIV-1 infection in vivo. Journal of Virology. 88: 11624-9. PMID 25031350 DOI: 10.1128/Jvi.01771-14  0.411
2014 Wang C, Abdel-Mohsen M, Strain MC, Lada SM, Yukl S, Cockerham LR, Pilcher CD, Hecht FM, Sinclair E, Liegler T, Richman DD, Deeks SG, Pillai SK. Decreased HIV type 1 transcription in CCR5-Δ32 heterozygotes during suppressive antiretroviral therapy. The Journal of Infectious Diseases. 210: 1838-43. PMID 24935955 DOI: 10.1093/Infdis/Jiu338  0.584
2014 Abdel-Mohsen M, Deng X, Liegler T, Guatelli JC, Salama MS, Ghanem Hel-D, Rauch A, Ledergerber B, Deeks SG, Günthard HF, Wong JK, Pillai SK. Effects of alpha interferon treatment on intrinsic anti-HIV-1 immunity in vivo. Journal of Virology. 88: 763-7. PMID 24155399 DOI: 10.1128/Jvi.02687-13  0.453
2013 Abdel-Mohsen M, Raposo RA, Deng X, Li M, Liegler T, Sinclair E, Salama MS, Ghanem Hel-D, Hoh R, Wong JK, David M, Nixon DF, Deeks SG, Pillai SK. Expression profile of host restriction factors in HIV-1 elite controllers. Retrovirology. 10: 106. PMID 24131498 DOI: 10.1186/1742-4690-10-106  0.444
2013 Raposo RA, Abdel-Mohsen M, Bilska M, Montefiori DC, Nixon DF, Pillai SK. Effects of cellular activation on anti-HIV-1 restriction factor expression profile in primary cells. Journal of Virology. 87: 11924-9. PMID 23966394 DOI: 10.1128/Jvi.02128-13  0.458
2013 Raposo RA, Abdel-Mohsen M, Holditch SJ, Kuebler PJ, Cheng RG, Eriksson EM, Liao W, Pillai SK, Nixon DF. Increased expression of intrinsic antiviral genes in HLA-B*57-positive individuals. Journal of Leukocyte Biology. 94: 1051-9. PMID 23929683 DOI: 10.1189/Jlb.0313150  0.42
2013 Yukl SA, Boritz E, Busch M, Bentsen C, Chun TW, Douek D, Eisele E, Haase A, Ho YC, Hütter G, Justement JS, Keating S, Lee TH, Li P, Murray D, ... ... Pillai S, et al. Challenges in detecting HIV persistence during potentially curative interventions: a study of the Berlin patient. Plos Pathogens. 9: e1003347. PMID 23671416 DOI: 10.1371/Journal.Ppat.1003347  0.595
2012 Pillai SK, Abdel-Mohsen M, Guatelli J, Skasko M, Monto A, Fujimoto K, Yukl S, Greene WC, Kovari H, Rauch A, Fellay J, Battegay M, Hirschel B, Witteck A, Bernasconi E, et al. Role of retroviral restriction factors in the interferon-α-mediated suppression of HIV-1 in vivo. Proceedings of the National Academy of Sciences of the United States of America. 109: 3035-40. PMID 22315404 DOI: 10.1073/Pnas.1111573109  0.472
2011 Skasko M, Tokarev A, Chen CC, Fischer WB, Pillai SK, Guatelli J. BST-2 is rapidly down-regulated from the cell surface by the HIV-1 protein Vpu: evidence for a post-ER mechanism of Vpu-action. Virology. 411: 65-77. PMID 21237475 DOI: 10.1016/J.Virol.2010.12.038  0.319
2010 Rempel H, Sun B, Calosing C, Pillai SK, Pulliam L. Interferon-alpha drives monocyte gene expression in chronic unsuppressed HIV-1 infection. Aids (London, England). 24: 1415-23. PMID 20495440 DOI: 10.1097/Qad.0B013E32833Ac623  0.422
2010 Wong JK, Strain MC, Porrata R, Reay E, Sankaran-Walters S, Ignacio CC, Russell T, Pillai SK, Looney DJ, Dandekar S. In vivo CD8+ T-cell suppression of siv viremia is not mediated by CTL clearance of productively infected cells. Plos Pathogens. 6: e1000748. PMID 20126442 DOI: 10.1371/Journal.Ppat.1000748  0.352
2010 Manosuthi W, Butler DM, Pérez-Santiago J, Poon AF, Pillai SK, Mehta SR, Pacold ME, Richman DD, Pond SK, Smith DM. Protease polymorphisms in HIV-1 subtype CRF01_AE represent selection by antiretroviral therapy and host immune pressure. Aids (London, England). 24: 411-6. PMID 20009919 DOI: 10.1097/Qad.0B013E3283350Eef  0.698
2010 Joos B, Rieder P, Fischer M, Kuster H, Rusert P, Trkola A, Pillai SK, Wong JK, Weber R, Günthard HF. Association between specific HIV-1 Env traits and virologic control in vivo. Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases. 10: 365-72. PMID 19524069 DOI: 10.1016/J.Meegid.2009.06.002  0.473
2009 Yukl S, Pillai S, Li P, Chang K, Pasutti W, Ahlgren C, Havlir D, Strain M, Günthard H, Richman D, Rice AP, Daar E, Little S, Wong JK. Latently-infected CD4+ T cells are enriched for HIV-1 Tat variants with impaired transactivation activity. Virology. 387: 98-108. PMID 19268337 DOI: 10.1016/J.Virol.2009.01.013  0.567
2009 Smith DM, Zárate S, Shao H, Pillai SK, Letendre SL, Wong JK, Richman DD, Frost SD, Ellis RJ. Pleocytosis is associated with disruption of HIV compartmentalization between blood and cerebral spinal fluid viral populations. Virology. 385: 204-8. PMID 19100592 DOI: 10.1016/J.Virol.2008.11.010  0.556
2008 Joos B, Fischer M, Kuster H, Pillai SK, Wong JK, Böni J, Hirschel B, Weber R, Trkola A, Günthard HF. HIV rebounds from latently infected cells, rather than from continuing low-level replication. Proceedings of the National Academy of Sciences of the United States of America. 105: 16725-30. PMID 18936487 DOI: 10.1073/Pnas.0804192105  0.454
2008 Kosakovsky Pond SL, Poon AF, Zárate S, Smith DM, Little SJ, Pillai SK, Ellis RJ, Wong JK, Leigh Brown AJ, Richman DD, Frost SD. Estimating selection pressures on HIV-1 using phylogenetic likelihood models. Statistics in Medicine. 27: 4779-89. PMID 18381707 DOI: 10.1002/Sim.3192  0.599
2008 Pilcher CD, Wong JK, Pillai SK. Inferring HIV transmission dynamics from phylogenetic sequence relationships. Plos Medicine. 5: e69. PMID 18351799 DOI: 10.1371/Journal.Pmed.0050069  0.459
2008 Pillai SK, Wong JK, Barbour JD. Turning up the volume on mutational pressure: is more of a good thing always better? (A case study of HIV-1 Vif and APOBEC3). Retrovirology. 5: 26. PMID 18339206 DOI: 10.1186/1742-4690-5-26  0.463
2007 Willberg CB, Pillai SK, Sharp ER, Rosenberg MG, Agudelo JD, Barbour JD, Nixon DF. Rational peptide selection to detect human immunodeficiency virus type 1-specific T-cell responses under resource-limited conditions. Clinical and Vaccine Immunology : Cvi. 14: 785-8. PMID 17409221 DOI: 10.1128/Cvi.00048-07  0.418
2007 Noviello CM, Pond SL, Lewis MJ, Richman DD, Pillai SK, Yang OO, Little SJ, Smith DM, Guatelli JC. Maintenance of Nef-mediated modulation of major histocompatibility complex class I and CD4 after sexual transmission of human immunodeficiency virus type 1. Journal of Virology. 81: 4776-86. PMID 17329339 DOI: 10.1128/Jvi.01793-06  0.504
2006 Smith DM, Strain MC, Frost SD, Pillai SK, Wong JK, Wrin T, Liu Y, Petropolous CJ, Daar ES, Little SJ, Richman DD. Lack of neutralizing antibody response to HIV-1 predisposes to superinfection. Virology. 355: 1-5. PMID 16962152 DOI: 10.1016/J.Virol.2006.08.009  0.568
2006 Pillai SK, Pond SL, Liu Y, Good BM, Strain MC, Ellis RJ, Letendre S, Smith DM, Günthard HF, Grant I, Marcotte TD, McCutchan JA, Richman DD, Wong JK. Genetic attributes of cerebrospinal fluid-derived HIV-1 env. Brain : a Journal of Neurology. 129: 1872-83. PMID 16735456 DOI: 10.1093/Brain/Awl136  0.598
2006 Coleman SH, Madrid R, Van Damme N, Mitchell RS, Bouchet J, Servant C, Pillai S, Benichou S, Guatelli JC. Modulation of cellular protein trafficking by human immunodeficiency virus type 1 Nef: role of the acidic residue in the ExxxLL motif. Journal of Virology. 80: 1837-49. PMID 16439540 DOI: 10.1128/Jvi.80.4.1837-1849.2006  0.322
2005 Pillai SK, Kosakovsky Pond SL, Woelk CH, Richman DD, Smith DM. Codon volatility does not reflect selective pressure on the HIV-1 genome. Virology. 336: 137-43. PMID 15892955 DOI: 10.1016/J.Virol.2005.03.014  0.544
2005 Strain MC, Letendre S, Pillai SK, Russell T, Ignacio CC, Günthard HF, Good B, Smith DM, Wolinsky SM, Furtado M, Marquie-Beck J, Durelle J, Grant I, Richman DD, Marcotte T, et al. Genetic composition of human immunodeficiency virus type 1 in cerebrospinal fluid and blood without treatment and during failing antiretroviral therapy. Journal of Virology. 79: 1772-88. PMID 15650202 DOI: 10.1128/Jvi.79.3.1772-1788.2005  0.6
2005 Pillai SK, Good B, Pond SK, Wong JK, Strain MC, Richman DD, Smith DM. Semen-specific genetic characteristics of human immunodeficiency virus type 1 env. Journal of Virology. 79: 1734-42. PMID 15650198 DOI: 10.1128/Jvi.79.3.1734-1742.2005  0.574
2004 Yu Q, König R, Pillai S, Chiles K, Kearney M, Palmer S, Richman D, Coffin JM, Landau NR. Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome. Nature Structural & Molecular Biology. 11: 435-42. PMID 15098018 DOI: 10.1038/Nsmb758  0.542
2003 Kunstman KJ, Puffer B, Korber BT, Kuiken C, Smith UR, Kunstman J, Stanton J, Agy M, Shibata R, Yoder AD, Pillai S, Doms RW, Marx P, Wolinsky SM. Structure and function of CC-chemokine receptor 5 homologues derived from representative primate species and subspecies of the taxonomic suborders Prosimii and Anthropoidea. Journal of Virology. 77: 12310-8. PMID 14581567 DOI: 10.1128/Jvi.77.22.12310-12318.2003  0.381
2003 Ali A, Pillai S, Ng H, Lubong R, Richman DD, Jamieson BD, Ding Y, McElrath MJ, Guatelli JC, Yang OO. Broadly increased sensitivity to cytotoxic T lymphocytes resulting from Nef epitope escape mutations. Journal of Immunology (Baltimore, Md. : 1950). 171: 3999-4005. PMID 14530319 DOI: 10.4049/Jimmunol.171.8.3999  0.538
2003 Pillai S, Good B, Richman D, Corbeil J. A new perspective on V3 phenotype prediction. Aids Research and Human Retroviruses. 19: 145-9. PMID 12643277 DOI: 10.1089/088922203762688658  0.532
2003 Pillai S, Good B, Richman D, Corbeil J. Sequence Note: A New Perspective on V3 Phenotype Prediction Aids Research and Human Retroviruses. 19: 347-347. DOI: 10.1089/088922203764969564  0.413
2002 Kalish ML, Korber BT, Pillai S, Robbins KE, Leo YS, Saekhou A, Verghese I, Gerrish P, Goh CL, Lupo D, Tan BH, Brown TM, Chan R. The sequential introduction of HIV-1 subtype B and CRF01AE in Singapore by sexual transmission: accelerated V3 region evolution in a subpopulation of Asian CRF01 viruses. Virology. 304: 311-29. PMID 12504572 DOI: 10.1006/Viro.2002.1691  0.352
2001 Nair MPN, Mahajan S, Chadha KC, Nair NM, Hewitt RG, Pillai SK, Chadha P, Sukumaran PC, Schwartz SA. Effect of cocaine on chemokine and CCR-5 gene expression by mononuclear cells from normal donors and HIV-1 infected patients Advances in Experimental Medicine and Biology. 493: 235-240. PMID 11727771 DOI: 10.1007/0-306-47611-8_28  0.333
Show low-probability matches.